The Effect of a 2000-m Ergometer Test on Training Status Indicators and the Muscle Adaptation in Rowers (ETTETTSIAMAR)

February 21, 2025 updated by: Poznan University of Physical Education

Multi-Faced Optimization of Sports Training Focused on Training Status Energy and Muscle Adaptation to Effort

Intense physical exercise can lead to micro-damage to tissues and activation of inflammatory processes, the body's natural response to exercise-related metabolic stress. Monitoring inflammation and fatigue will enable the observation of athletes in terms of post-exercise regeneration and muscle adaptation to physical effort. The obtained results will allow for estimating the level of fatigue, minimizing the risk of injury, and will show the rate of post-exercise regeneration or its absence.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The study will involve 40 members of the Polish Youth Rowing Team, both sexes, aged 19-23. The study will be held on three dates related to the specifics of the athletes' training cycle, i.e. in the preparatory period (March), the competition period (June), and the detraining period (November). The participants will perform an intensive exercise test on a rowing ergometer (manufacturer: Concept II, USA), covering a distance of 2,000 meters in the shortest possible time. The study will involve 40 members of the Polish Youth Rowing Team, both sexes, aged 19-23. Each time, before starting the exercise test, a non-invasive anthropometric analysis will be performed using the TANITA MC-780MA body composition analyzer (tanita Japan), to determine the body composition: percentage of body fat, body fat mass, lean tissue mass, muscle mass, body water and body mass index (BMI). On the three indicated dates, before and after the stress test, capillary blood (ear lobe) from the cubital vein will be collected from the participants. Using immunoenzymatic ELISA tests, the following will be determined: EPO (erythropoietin), VEGF (vascular endothelial growth factor), CRP (C-reactive protein), glycogen, hypoxanthine (Hx). Glucose level will be determined using an Accu-Chek Active glucometer (Roche, Germany).

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Polska
      • Gorzów Wielkopolski, Polska, Poland, 66-400
        • Poznań University of Physical Education, Faculty of Physical Culture in Gorzów Wielkopolski

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • members of the Polish Youth Rowing Team - competitors officially called up to the Polish national rowing team,
  • no musculoskeletal injuries that would prevent them from performing the exercise test,
  • written consent of the competitor to participate in the study.

Exclusion Criteria:

  • anti-inflammatory drugs, other supplements in the last 3 months before starting the study,
  • failure to complete the test,
  • current injury, post-traumatic condition, illness,
  • lack of informed consent of the athlete.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Physical effort
The effort on the rowing ergometer, based on swimming a specified distance in the shortest possible time.
The examined rowers will be subjected to an effort on a rowing ergometer, consisting of covering a designated distance in the shortest possible time.
Other Names:
  • Rowing ergometer test

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EPO (erythropoietin) level
Time Frame: Immediately before the ergometer test, immediately after and 3 hours after the test
Immunoenzymatic assay method using a diagnostic ELISA Kit
Immediately before the ergometer test, immediately after and 3 hours after the test
VEGF (vascular endothelial growth factor) level
Time Frame: Immediately before the ergometer test, immediately after and 3 hours after the test
Immunoenzymatic assay method using a diagnostic ELISA Kit
Immediately before the ergometer test, immediately after and 3 hours after the test
Hypoxanthine (Hx) level
Time Frame: Immediately before the ergometer test, immediately after and 3 hours after the test
Immunoenzymatic assay method using a diagnostic ELISA Kit
Immediately before the ergometer test, immediately after and 3 hours after the test
Glycogen level
Time Frame: Immediately before the ergometer test, immediately after and 3 hours after the test
Immunoenzymatic assay method using a diagnostic ELISA Kit
Immediately before the ergometer test, immediately after and 3 hours after the test
Glucose level
Time Frame: Immediately before the ergometer test, immediately after and 3 hours after the test
Using an Accu-Chek Active glucometer (Roche, Germany)
Immediately before the ergometer test, immediately after and 3 hours after the test

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anna Kasperska, PhD, Poznań University of Physical Education, Faculty of Sport Sciences in Gorzów Wielkopolski, Poland;

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2024

Primary Completion (Actual)

November 30, 2024

Study Completion (Actual)

November 30, 2024

Study Registration Dates

First Submitted

January 9, 2025

First Submitted That Met QC Criteria

February 21, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 21, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Rowers 2024
  • RPW/8857/2024 (Other Identifier: Ministry of Sport and Tourism)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exhaustion - Physiological

Clinical Trials on Physical effort

Subscribe